CDSCO Panel Grants Go Ahead for Levim Lifetech’s Phase I/III Teriparatide Trial
New Delhi: The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has recommended grant of permission to Levim Lifetech Private Limited to conduct a Phase I/III…